Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Cell. 1993 Mar 12;72(5):729-39. doi: 10.1016/0092-8674(93)90401-b.
Bcl-3 is an I kappa B-related protein with ankyrin repeat motifs. Its gene is located at a site of recurrent translocations in a subset of B cell chronic lymphocytic leukemias. Bcl-3 associates tightly with p50B (NFKB2, p52) homodimers in cells, and together these proteins form a ternary complex with DNA at kappa B sites. Such an association functionally leads to a novel and potent form of transactivation through the kappa B motif: the tethering of Bcl-3 to DNA via the p50B homodimers allows Bcl-3 to transactivate directly, while p50B homodimers alone cannot. Transactivation mediated by Bcl-3 requires two cooperating domains located amino- and carboxy-terminal to the ankyrin domain. Bcl-3 is localized to the nucleus, and a Bcl-3-p50B complex is detected in certain lymphoid cells. Our data reveal a novel role for Bcl-3, distinct from that of the inhibitor I kappa B. The results have implications for tumorigenesis.
Bcl-3是一种具有锚蛋白重复基序的IκB相关蛋白。其基因位于一部分B细胞慢性淋巴细胞白血病中出现反复易位的位点。在细胞中,Bcl-3与p50B(NFKB2,p52)同二聚体紧密结合,并且这些蛋白一起在κB位点与DNA形成三元复合物。这种结合在功能上通过κB基序导致一种新的、有效的反式激活形式:Bcl-3通过p50B同二聚体与DNA相连,使得Bcl-3能够直接进行反式激活,而单独的p50B同二聚体则不能。由Bcl-3介导的反式激活需要位于锚蛋白结构域氨基端和羧基端的两个协同结构域。Bcl-3定位于细胞核,并且在某些淋巴细胞中检测到Bcl-3-p50B复合物。我们的数据揭示了Bcl-3的一种与抑制剂IκB不同的新作用。这些结果对肿瘤发生具有启示意义。